PureTech Announces Annual Results for Year Ended December 31

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...

Related Keywords

United Kingdom , Massachusetts , United States , Delaware , London , City Of , Boston , American , Bharatt Chowrira , La Monte Carlo , Daphne Zohar , Castro Pereira , Pirfenidone Esbriet , Eric Elenko , Monte Carlo , Bristol Myers Squibb , Karuna Kar , Raju Kucherlapati , Eli Lilly , Stevenm Paul , Robert Langer , Sven Dethlefs , Julie Krop , Bristol Meyers Squibb , Charles Sherwood , Wakili , John Lamattina , Teva Pharmaceuticals , Us Department Of Defense , Foreign Currency Exchange Risk , Censof Holdings , European Medicines Agency , Company As Founded Entities , Public Health Emergency , Angel Court , Group Controlled Founded Entities , Group Consolidated Statement Of Comprehensive Income Loss , Bankruptcy Court , Endra Holdings , United International Financial Reporting Standards Ifrss , None Of The Group , Merck Co , Vedanta Biosciences Inc , Vor Bio Inc , Development Expenses , Puretech Management Inc , Group Board Of Directors , Clinical Development Success , Party Subleases , Investments In Associates , Vedanta Biosciences Securities Corp , Revenue Service , Parent Company Other , Companies House , Jefferies International Limited , Group On Karuna , Parent Company Statement Of Cash , Capital Suvretta Holdings Corp , Parent Company Statement Of Financial Position , Group The Consolidated Financial , Ensof Biosystems Inc , Sonde Health Inc , Caviar Merger Sub , Europe Health Care Index , Vedanta Inc , Senior Leadership Team , International Accounting Standards Board , Financial Statements Of Puretech Health , Junior , Ariya Therapeutics Inc , Mandara Sciences , Karuna Therapeutics Inc , Puretech Securities Corporation , Action Fund , Imbrium Therapeutics Inc , International Conference On Relapse After , Auspex Pharmaceuticals Inc , Gallop Oncology Inc , Financial Statements Of The Group , Group Remuneration Committee , Financial Conduct Authority Listing Rule , Foreign Exchange Risk , Massachusetts District Court , Puretech Health , Group Consolidated Financial , Securities Exchange , Akili Interactive Labs Inc , Owners Of The Group , Gelesis Inc , Group Consolidated Statement Of Financial Position , Twitter , Group Directors , Parent Company Financial , Gelesis Holdings Inc , Puretech Securities Ii Corp , Whilst The Group , United Kingdom Listing Authority , Vor Biopharma Inc , Main Market Of The London Stock Exchange , Follica Incorporated , Entrega Inc , National Storage Mechanism , Tal Medical Inc , Commense Inc , Sonde Health , Investment In Associates , Appeering Inc , Knode Inc , York Stock Exchange , Journal Of The American Medical Association , Corporation Trust Center , Oxford Finance , Puretech Seaport Therapeutics Inc , Capstar Special Purpose Acquisition Corp , Puretech Securities Ii Corporation , Puretech Securities Corp , Rd Committee , Parent Company , Nasdaq , Exchange Commission , London Stock Exchange , New York Stock Exchange , Application Of The Equity Method To Associates , Exchange Of Gelesis , Melinda Gates Foundation , Alivio Therapeutics Inc , Puretech Lyt Inc , Libra Biosciences Inc , Associates Accounted For Using The Equity Method , Enlight Biosciences , Drug Administration , United Kingdom Annual Report , Annual Report , United States Securities , Tech Announces Annual Results , Year Ended December , Business Wire , Chief Executive Officer , Founded Entities , Founded Entity , Seaport Therapeutics , Internal Programs , Gallop Oncology , Fast Track , New Drug Application , Myers Squibb , Royalty Pharma , American Medical Association , International Conference , Relapse After Transplant , Cellular Therapy , Executive Director , Puretech President , Chief Innovation Officer , General Counsel , Vice President , Corporate Legal Counsel , Seaport Series , Tender Offer , Tech Health , Financial Conduct Authority , Listing Rule , Investor Relations , Private Securities Litigation Reform Act , Founded Entitie , Non Controlled Founded Entities , Akili Interactive Labs , Vor Bio , Vedanta Biosciences , Karuna Therapeutics , Viability Statement , Financial Review , Financial Statements , Consolidated Financial , Clinical Development Success Rates , Enforcement Policy , Digital Health Devices , Treating Psychiatric Disorders During , Coronavirus Disease , Public Health , Chief Medical Officer , Puretech Board , Chief Executive , Chief Operating Officer , Sirna Therapeutics , Chief Business , Operating Officer , Internal Program , Fragilex Associated Ataxia Syndrome , Sofinnova Investments , Third Rock , Puretech Founding , Prescription Drug User Fee Act , Executive Officer , Predicting Life Expectancy , Idiopathic Pulmonary , Managed Care , Specialty Pharmacy , New England Journal , Third Rock Ventures , Consolidated Financial Statements ,